- Home
- Publications
- Publication Search
- Publication Details
Title
Asplatin enhances drug efficacy by altering the cellular response
Authors
Keywords
-
Journal
Metallomics
Volume 8, Issue 7, Pages 672-678
Publisher
Royal Society of Chemistry (RSC)
Online
2016-04-15
DOI
10.1039/c6mt00066e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
- (2016) Raji Raveendran et al. Chemical Science
- Oral delivery of a platinum anticancer drug using lipid assisted polymeric nanoparticles
- (2015) Qinqin Cheng et al. CHEMICAL COMMUNICATIONS
- A Nanoparticle Cocktail: Temporal Release of Predefined Drug Combinations
- (2015) Rakesh K. Pathak et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
- (2014) Rakesh K. Pathak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
- (2014) Qinqin Cheng et al. CHEMICAL COMMUNICATIONS
- Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
- (2014) Wilma Neumann et al. ChemMedChem
- Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
- (2013) Shanthi Ganesh et al. Molecular Therapy-Nucleic Acids
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
- (2012) Annemijn M Algra et al. LANCET ONCOLOGY
- Priming effect of aspirin for tumor cells to augment cytotoxic action of cisplatin against tumor cells: implication of altered constitution of tumor microenvironment, expression of cell cycle, apoptosis, and survival regulatory molecules
- (2012) Anjani Kumar et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers
- (2012) Kristina W. Thiel et al. NUCLEIC ACIDS RESEARCH
- Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells
- (2011) Soon Yang Low et al. CANCER LETTERS
- Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells
- (2011) Haider Raza et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pt(IV) complexes as prodrugs for cisplatin
- (2011) Yi Shi et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Aspirin Extrusion From Human Platelets Through Multidrug Resistance Protein-4–Mediated Transport
- (2011) Teresa Mattiello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- The BCL-2 Family Reunion
- (2010) Jerry E. Chipuk et al. MOLECULAR CELL
- Caspase activation pathways: some recent progress
- (2009) S P Cullen et al. CELL DEATH AND DIFFERENTIATION
- Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma
- (2009) W. A. Michaud et al. CLINICAL CANCER RESEARCH
- Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial
- (2009) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
- (2009) Bernard F. Cole et al. JNCI-Journal of the National Cancer Institute
- Aspirin, salicylates, and cancer
- (2009) Peter C Elwood et al. LANCET
- Bcl-2 Proteins and Apoptosis: Choose Your Partner
- (2008) Gordon C. Shore et al. CELL
- Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
- (2008) H. Choy et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started